Chronic lung disease (CLD) is the most prevalent chronic respiratory illness during infancy among surviving premature infants. 1 In other chronic respiratory diseases, substantial proportions of affected patients have gastroesophageal reflux (GER). [2] [3] [4] Using either an esophageal pH probe or an upper gastrointestinal contrast study for the diagnosis, Hrabovsky and Mullett 5 observed an increased rate of GER in infants with CLD. In contrast, Jolley et al. 6 found no association between CLD and GER, and Sindel et al. 7 found a decreased likelihood of GER in infants with CLD.
The present study was undertaken with the primary objective of analyzing the association between neonatal CLD and clinically diagnosed GER in very low birth weight (VLBW) infants. Because we suspected that many infants were treated presumptively without objective testing for GER, we also analyzed whether the risk of GER increased with increasing severity of CLD. The underlying supposition in these analyses was that the association between GER and the severity of CLD, as opposed to the presence or absence of CLD, would be less confounded by biased ascertainment of GER. A secondary objective was to assess whether clinically diagnosed GER was associated with delayed growth and development during infancy.
METHODS

Subjects
Study subjects included all VLBW (Յ1500 gm) infants with CLD, born between January of 1985 and May of 1995, who were cared for in either of two level 3 nurseries (Brenner Children's Hospital and Forsyth Medical Center) in North Carolina, which together are the sole providers of neonatal intensive care in a 17-county region. From a computerized database of all admissions to the two nurseries, we identified 431 consecutively born VLBW infants with CLD, defined as the need for supplemental oxygen at 36 weeks postconceptional age, 8 who survived to 1 year of age. Follow-up information at 1 year corrected age was available for 375 (87%) infants. For each of these 375 infants with CLD, a control infant was selected who also survived to 1 year corrected age. Controls were VLBW infants without CLD, who were born closest in time to, and with a gestational age within 1 week of, the infant with CLD. Follow-up clinic records were available for 92% (345 of 375) of control infants. This sample size provided Ն95% power to detect an odds ratio (OR) of Ն2 for the occurrence of GER among infants with CLD, compared with controls, assuming an incidence among the latter group of at least 0.10 (␣ ϭ 0.05). For adverse outcomes with a frequency of 15% to 20% among infants without GER, the sample Original Article
provided ϳ80% power to detect a doubling of the risk among infants with GER.
Data and Definitions
Medical records were reviewed by a neonatologist, and information about the following was collected: (1) use of one or more promotility agents (metaclopramide, bethanecol, or cisapride) and/or H 2 -blocking agents (cimetidine or ranitidine) during the first year of life (including use after discharge from the hospital), (2) results of tests for GER (esophageal pH probe, upper gastrointestinal contrast studies, and microscopic examination of tracheal aspirates for lipid laden macrophages), and (3) whether anti-reflux surgery (fundoplication) was performed. For the purpose of this study, clinically diagnosed GER was defined as either treatment with anti-reflux medications (listed above) or a positive test for GER. Tests for GER were performed and treatment was initiated at the discretion of the attending neonatologist. Typically, a trial of anti-reflux medications was begun in the presence of the following symptoms: back arching or irritability during or soon after feedings, 7,9,10 growth failure attributed to excessive regurgitation of feedings, 9, 11, 12 recurrent aspiration pneumonitis, 12, 13 worsening apnea as volume of the feedings was increased, apnea occurring predominantly after feedings, 14 -17 apnea in infants with a postconceptional age of Ͼ36 weeks, 18 or a positive test for GER. Infants whose symptoms persisted even after initiation of anti-reflux therapy usually underwent testing for confirmation of the diagnosis.
Severity of CLD was indicated using two measures: the number of days the infant required supplemental oxygen and the type of abnormality on the infant's chest radiograph. Among ventilated preterm infants, infants with hyperinflation or cystic changes on chest radiograph (referred to by Hyde et al. 19 as "type 2" changes) are more likely to die from CLD compared with infants with homogenous opacity and no hyperinflation.
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Outcome Data at 1 Year of Age All study infants underwent a multidisciplinary evaluation at 1 year corrected age, including a history and physical examination by a pediatrician and administration of the Bayley Scales of Infant Development 21, 22 by a child psychologist. After October of 1993, the 2nd edition of the Bayley Scales of Infant Development was used. Pediatricians were aware of pertinent aspects of the neonatal history such as the results of cranial ultrasonography and the diagnosis of CLD and GER. Psychologists were aware of the infant's gestational age (to permit adjustment of the Bayley Scales for the degree of prematurity), but remained unaware of the remaining neonatal history.
For the present study, delayed mental and motor development were defined, respectively, as a Bayley Scales Mental Developmental Index or Psychomotor Developmental Index of Ͻ70. The diagnosis of cerebral palsy was made only if a pediatrician and pediatric physical therapist agreed on the presence of abnormal control of movement and posture. Delayed growth was defined as weight, length, or head circumference below the 10th percentile, as determined from reference curves. 23 
Data Analysis
Group comparisons for categorical and continuous variables were performed using the -squared test (with Yates correction) and Wilcoxon rank sum test, respectively. Confounding was assessed using logistic regression models (Logist procedure 24 ).
RESULTS
Characteristics of Study Infants
As shown in Table 1 , infants with and without CLD were similar with respect to gestational age. Infants with CLD had a lower birth weight, and a larger proportion were male or small for gestational age. Intraventricular hemorrhage was present more often in infants with CLD, and these infants spent more days on assisted ventilation, on supplemental oxygen, and in the hospital.
CLD and Treatment and Tests for GER
As depicted in esophageal pH monitoring, was positive in 69% of infants with clinical signs suggestive of GER.
Assessment of Confounding
As shown in Table 3 , GER occurred more frequently among males, white infants, and infants with indicators of more severe lung disease (days on oxygen and days on ventilator). Decreasing gestational age, but not birth weight, was weakly associated with an increased risk of GER. Cranial ultrasound abnormalities were not associated with GER. The association between CLD and GER persisted when adjusted for gestational age, gender, race, days on assisted ventilation, and days of hospitalization [multivariate OR ϭ 2.1 (1.1 to 3.5)].
Predictors of Treatment for GER Among Infants With CLD
Other than being small for gestational age, none of the characteristics listed in Table 4 was associated with treatment for GER. In particular, indicators of increasing severity of lung disease (hyperinflation on chest radiography and the number of days on mechanical ventilation or supplemental oxygen) were not predictive of GER.
GER and 1-Year Outcomes in Infants With CLD
The results of developmental and growth assessments for infants with CLD at 1 year corrected age are depicted in Table 5 . Comparing infants with and without GER, no difference was found in the likelihood of delayed growth or a developmental problem (a Bayley Mental Developmental Index or Psychomotor Developmental Index of Ͻ70 or cerebral palsy).
DISCUSSION
The principal finding of this study is that the likelihood of clinically diagnosed GER is increased among infants with CLD. To the extent that this outcome is a valid indicator of GER, this finding supports earlier work by Hrabovsky et al., 5 who have described an association between CLD and GER. Our results differ from those of Jolley et al., 6 who found no association between GER and CLD. In that study, however, control infants had symptoms potentially attributable to GER, including respiratory symptoms; thus the incidence of GER in these controls might have been biased upwards. Contrary to our hypothesis, we found no association between indicators of the severity of CLD and the likelihood of GER, consistent with the possibility that the association between CLD and GER is explained by biased diagnostic suspicion rather than by biologic mechanisms.
Nevertheless, there are at least two reasons why a causal relationship between CLD and GER seems likely. First, pharmacologic therapies used in preterm infants for the treatment of apnea (methylxanthines including aminophylline, theophylline, and caffeine) may result in decreased tone of the lower esophageal sphincter, aggravating GER. 25 Second, hyperinflation of the lungs in infants with CLD may lead to the lower esophageal sphincter being in the thoracic cavity and increased intra-abdominal pressure during expiration, leading to GER. 5, 26 Along with these theoretical considerations, our study and that of Hrabovsky et al. 5 should be regarded as providing tentative support for an association between CLD and GER.
A second finding of our study was that clinically diagnosed GER was not associated with a higher risk of growth or developmental delay among infants with CLD. It has been shown previously by deRegnier et al. 27 that CLD itself increases the risk of growth and developmental problems in VLBW infants. We found no evidence that GER is a contributory factor in this regard, although another interpretation of our findings would be that when treated appropriately, GER does not affect growth or development. Although our study did not have adequate power to detect modest-sized effects of GER on developmental status, it does provide some reassurance that GER, and the medications used to treat GER, do not increase the risk of adverse outcomes.
The principal limitation of our study is the lack of prospective criteria for diagnosing GER. Each of the clinical signs that were used as justification for treatment with anti-reflux medications are nonspecific. For example, apnea of prematurity may persist beyond 36 weeks in a majority of infants born at 24 to 27 weeks' gestation. 18 Thus some infants who were suspected of having GER based on apnea persisting beyond 36 weeks may have been incorrectly diagnosed. In the absence of prospective diagnostic criteria, clinicians probably had a higher index of suspicion in infants with CLD. Thus, we wish to emphasize that the association that we observed, between CLD and GER, could be entirely attributable to biased ascertainment of GER.
Although other authors have based the diagnosis of GER on a positive esophageal pH probe or an upper gastrointestinal contrast study, clinically diagnosed reflux, as was studied here, might also be an important outcome, if the clinician's goal is to identify patients who might benefit from treatment for GER. Because the current "gold standard" test for acid reflux, an esophageal pH probe study, 28 fails to diagnose reflux of nonacidic gastric contents, perhaps future investigations should include not just esophageal pH testing, but also a set of clinical criteria for diagnosing GER.
Some of the difficulty inherent in studying the relationship between CLD and GER derives from the fact that the times of onset of CLD and GER are variable. In an observational study, it may be impossible to determine the direction of causation, if a causal association exists between CLD and GER. The relationship between CLD and GER may be better understood by evaluating a cohort of VLBW infants at intervals for GER using an esophageal pH probe and clinical symptoms, and then evaluating the response to randomly assigned antireflux therapy in infants with either a positive pH probe or symptoms suggestive of GER.
